Search research articles
Contact Us
Filters
Showing results (71-80 of 93) with videos related to
Page
of 10
Sort By:
Journal of Clinical Medicine
|
January 21, 2023
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)
Ivan J Núñez-Gil, Gisela Feltes, María C Viana-Llamas, et al.
Journal of Clinical Medicine
|
May 11, 2024
Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes-Results from a Multi-Center International Prospective Registry (HOPE-2)
Ravi Vazirani, Gisela Feltes, Rafael Sánchez-Del Hoyo, et al.
Frontiers in Endocrinology
|
June 1, 2023
Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry
Mohammad Abumayyaleh, Iván J Núñez Gil, María C Viana-LLamas, et al.
Biomedicines
|
November 27, 2025
The Long-Term Outcomes of Corticosteroid Use in COVID-19 Patients with Cardiovascular Disease: A Propensity-Matched Analysis from the Multi-Center International Prospective Registry (HOPE-2)
Jorge García-Onrubia, Ravi Vazirani, Gisela Feltes, et al.
Minerva Cardiology and Angiology
|
June 17, 2021
Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry
Sara Al Raisi, Majd Protty, Sergio Raposeiras-Roubín, et al.
BMJ Open
|
January 8, 2025
Clinical validation of an artificial intelligence-based decision support system for diagnosis and risk stratification of heart failure (STRATIFYHF): a protocol for a prospective, multicentre longitudinal study
Sarah Jane Charman, Nduka C Okwose, Amy Groenewegen, et al.
Journal of Clinical Medicine
|
June 10, 2023
Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19
Alba Mulet, Iván J Núñez-Gil, Juan Antonio Carbonell, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
November 1, 2022
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry
Michele Millesimo, Edoardo Elia, Giorgio Marengo, et al.
European Heart Journal. Acute Cardiovascular Care
|
October 2, 2018
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI
Federico Conrotto, Maurizio Bertaina, Sergio Raposeiras-Roubin, et al.
International Journal of Cardiology
|
September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry
Fabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 93) with videos related to
Sort By:
Page
of 10
Journal of Clinical Medicine
|
January 21, 2023
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)
Ivan J Núñez-Gil, Gisela Feltes, María C Viana-Llamas, et al.
Journal of Clinical Medicine
|
May 11, 2024
Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes-Results from a Multi-Center International Prospective Registry (HOPE-2)
Ravi Vazirani, Gisela Feltes, Rafael Sánchez-Del Hoyo, et al.
Frontiers in Endocrinology
|
June 1, 2023
Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry
Mohammad Abumayyaleh, Iván J Núñez Gil, María C Viana-LLamas, et al.
Biomedicines
|
November 27, 2025
The Long-Term Outcomes of Corticosteroid Use in COVID-19 Patients with Cardiovascular Disease: A Propensity-Matched Analysis from the Multi-Center International Prospective Registry (HOPE-2)
Jorge García-Onrubia, Ravi Vazirani, Gisela Feltes, et al.
Minerva Cardiology and Angiology
|
June 17, 2021
Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry
Sara Al Raisi, Majd Protty, Sergio Raposeiras-Roubín, et al.
BMJ Open
|
January 8, 2025
Clinical validation of an artificial intelligence-based decision support system for diagnosis and risk stratification of heart failure (STRATIFYHF): a protocol for a prospective, multicentre longitudinal study
Sarah Jane Charman, Nduka C Okwose, Amy Groenewegen, et al.
Journal of Clinical Medicine
|
June 10, 2023
Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19
Alba Mulet, Iván J Núñez-Gil, Juan Antonio Carbonell, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
November 1, 2022
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry
Michele Millesimo, Edoardo Elia, Giorgio Marengo, et al.
European Heart Journal. Acute Cardiovascular Care
|
October 2, 2018
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI
Federico Conrotto, Maurizio Bertaina, Sergio Raposeiras-Roubin, et al.
International Journal of Cardiology
|
September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry
Fabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
Page
of 10